Fluidigm Raises $18.2M in Private Stock Sale | GenomeWeb

NEW YORK (GenomeWeb News) – Fluidigm has raised $18.2 million through the private placement of an undisclosed number of shares, according to a filing with the US Securities and Exchange Commission.

The South San Francisco, Calif.-based firm is seeking to raise up to a total of $24.1 million from the offering, according to the SEC filing.

A Fluidigm spokesman confirmed the amount of money raised so far, but he could not provide any further details at this time.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."